Parth Sodha

Am I audible?

My question is like over the 3 years, Strides has successfully diversified beyond the U.S., but the long-term aspiration of around USD400 million revenue by FY28 remains largely dependent on complex products and controlled substance. Let's say, if this opportunity takes longer than expected, what will be the next structural growth engine that can sustain double -digit earnings growth beyond FY28?